Bioresorbable scaffolds for natural breast reconstruction
Read More
WHO WE ARE
Tensive is a clinical-stage medical device company developing the REGENERA™ / SOFTAG™ resorbable biopolymer scaffolds.
REGENERA™/SOFTAG™ for natural breast reconstruction and tissue marking following lumpectomy
Excellent safety profile — Encouraging secondary performance endpoints — High levels of patient and surgeon satisfaction
100
+100
+patients implanted
23
mln23
mlnraised
We Take Care Of Your Healthy Accept Medical Insurance
Check out our latest
Tensive publishes positive interim pivotal clinical data showing REGENERA™ supports natural breast reconstruction in Updates in Surgery
Milan, Italy – April 15, 2026 – Tensive S.r.l., a clinical-stage advanced biomaterials medical device company developing REGENERA™ bioresorbable scaffolds […]
Independent study presented at ECR highlights REGENERA™ bioresorbable scaffold potential for breast restoration after lumpectomy
Milan, Italy – March 04, 2026 – Tensive S.r.l, a clinical-stage advanced biomaterials medical device company developing REGENERA™ bioresorbable scaffolds […]
Tech Tour Growth50 Europe 2026 – Paris – March 17, 2026
Tensive has been selected for the Tech Tour Growth50 Europe 2026 Listing, which recognizes Europe’s top 50 technology companies with […]
Tensive reports positive pivotal trial top-line results showing REGENERA™ bioresorbable device may transform breast reconstruction
Milan, Italy – January 8, 2026 – Tensive S.r.l, a clinical-stage advanced biomaterials medical device company developing REGENERA™/SOFTAG™ bioresorbable scaffolds […]
J.P. Morgan Healthcare Week – San Francisco – January 12-15, 2026
Tensive will be in San Francisco for meetings with investors, partners and journalists during the JP Morgan Healthcare Conference (week […]
Tensive publishes positive long-term clinical follow-up data in Breast Cancer on REGENERA™ / SOFTAG™ breast implant
Press release in italian Milan, Italy – 9 October, 2025 Tensive S.r.l, a clinical-stage advanced biomaterials medical device company developing […]
Tensive provides positive clinical updates highlighting potential of REGENERA™ / SOFTAG™ device to transform post-cancer breast reconstruction
Press release in italian Clinical data from two ongoing trials in patients undergoing lumpectomy confirm strong safety profile and growing […]
LSI Europe – London – 7-11 September, 2025
Tensive Chief Executive Officer Sanjay Kakkar will speak at LSI Europe 2025, as one of the innovators selected to take […]
Tensive appoints medical device veteran Bill Hunter Chairman as its bioresorbable scaffold for breast reconstruction after cancer approaches market
Press release in italian Has more than 30 years of experience bringing innovations to market, including one of the world’s […]
Tensive raises €14,000,000 Series A Financing Round led by Panakès Partners SGR to transform breast reconstruction following lumpectomy. Appoints Sanjay Kakkar as Chief Executive Officer
Platform based on innovative polymeric scaffolds applied as bio-absorbable implants Initially being developed in breast cancer reconstruction and breast augmentation […]